Published on
July 22, 2023
- 00:00 GMT
Summary of opinion: Degarelix Accord,degarelix acetate, 20/07/2023, Positive
On 20 July 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Degarelix Accord, intended for the treatment of hormone dependent …
Distribution channels:
Healthcare & Pharmaceuticals Industry
